1.
Azad A, Herbertson RA, Pook D, White S, Mitchell PLR, Tebbutt NC. Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma. AO [Internet]. 2009 Jan. 1 [cited 2024 Nov. 21];48(4):619-21. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25492